U.S. flag

An official website of the United States government

NM_004780.3(TCEAL1):c.169del (p.Leu57fs) AND Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 12, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003152645.4

Allele description [Variation Report for NM_004780.3(TCEAL1):c.169del (p.Leu57fs)]

NM_004780.3(TCEAL1):c.169del (p.Leu57fs)

Gene:
TCEAL1:transcription elongation factor A like 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
Xq22.2
Genomic location:
Preferred name:
NM_004780.3(TCEAL1):c.169del (p.Leu57fs)
HGVS:
  • NC_000023.11:g.103630085del
  • NM_001006639.2:c.169del
  • NM_001006640.2:c.169del
  • NM_004780.3:c.169delMANE SELECT
  • NP_001006640.1:p.Leu57fs
  • NP_001006641.1:p.Leu57fs
  • NP_004771.2:p.Leu57fs
  • NC_000023.10:g.102885013del
  • NM_001006639.2:c.169delC
Nucleotide change:
1-BP DEL, 169C
Protein change:
L57fs
Links:
OMIM: 300237.0005; dbSNP: rs2147641837
NCBI 1000 Genomes Browser:
rs2147641837
Molecular consequence:
  • NM_001006639.2:c.169del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001006640.2:c.169del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_004780.3:c.169del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked (HIJRS)
Synonyms:
HIJAZI-REIS SYNDROME
Identifiers:
MONDO: MONDO:0859085; MedGen: C5774179; OMIM: 301094

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003841021OMIM
no assertion criteria provided
Pathogenic
(Sep 12, 2023)
germlineliterature only

Hijazi, H., Reis, L. M., Pehlivan, D., Bernstein, J. A., Muriello, M., Syverson, E., Bonner, D., Estiar, M. A., Gan-Or, Z., Rouleau, G. A., Lyulcheva, E., Greenhalgh, L., and 26 others TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions. Am. J. Hum. Genet. 109: 2270-2282, 2022.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Details of each submission

From OMIM, SCV003841021.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided

Description

In a 6-year-old girl (individual 7) with Hijazi-Reis syndrome (HIJRS; 301094), Hijazi et al. (2022) identified a de novo heterozygous 1-bp deletion (c.169delC, NM_001006639.2) in exon 3 of the TCEAL1 gene, predicted to result in a frameshift and premature termination (Leu57SerfsTer36). The mutation was found by exome sequencing. Functional studies of the variant and studies of patient cells were not performed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023